News

Funding for epilepsy research lags behind Alzheimer’s, autism


 

Funding of epilepsy research from the National Institutes of Health has increased by 9% since 2007, compared with increases of 37% for Alzheimer’s research and 106% for autism, according to data from the NIH’s Research, Condition, and Disease Categorization system.

NIH funding for epilepsy research was $145 million in 2007 and is expected to be about $158 million in 2014. Funding for research on Alzheimer’s disease went from $411 million in 2007 to an estimated $562 million in 2014, and autism funding increased from $93 million to $192 million. In comparison, the NIH spent about $143 million on Parkinson’s disease research in 2007 and will spend an estimated $156 million in 2014.

The situation is similar on the private-sector side of the equation. Private funding for epilepsy research was $10 million in 2011, compared with $16 million for Alzheimer’s disease, $63 million for autism, and $59 million for Parkinson’s disease, according to a report from Citizens United for Research in Epilepsy.

rfranki@frontlinemedcom.com

Recommended Reading

Anxiety associated with structural brain differences in children with epilepsy
MDedge Neurology
New and Noteworthy Information—August 2013
MDedge Neurology
New and Noteworthy Information—September 2013
MDedge Neurology
New and Noteworthy Information—October 2013
MDedge Neurology
Measles vaccination at 12-15 months = lower seizure risk
MDedge Neurology
Study finds brivaracetam well tolerated but with unclear efficacy
MDedge Neurology
Study explores markers for risk of sudden death in epilepsy
MDedge Neurology
NINDS seeks comment on draft epilepsy research agenda
MDedge Neurology
Now open: 146 epilepsy clinical trials
MDedge Neurology
Features of Lennox-Gastaut syndrome of unknown cause described in large study
MDedge Neurology